Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2122-2137
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2122
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2122
Figure 4 Levels of synaptophysin-like 2 expression in colorectal cancer patients from GSE60331 who did and did not respond to bevacizumab treatment.
aP < 0.05.
- Citation: Zhao ZX, Liu QL, Yuan Y, Wang FS. Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients. World J Gastrointest Oncol 2022; 14(11): 2122-2137
- URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2122.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2122